Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial

INTRODUCTION: Over 70% of all hospital admissions have a peripheral intravenous device (PIV) inserted; however, the failure rate of PIVs is unacceptably high, with up to 69% of these devices failing before treatment is complete. Failure can be due to dislodgement, phlebitis, occlusion/infiltration a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Open
Main Authors: Rickard, Claire M, Marsh, Nicole, Webster, Joan, Playford, E Geoffrey, McGrail, Matthew R, Larsen, Emily, Keogh, Samantha, McMillan, David, Whitty, Jennifer A, Choudhury, Md Abu, Dunster, Kimble R, Reynolds, Heather, Marshall, Andrea, Crilly, Julia, Young, Jeanine, Thom, Ogilvie, Gowardman, John, Corley, Amanda, Fraser, John F
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2015
Teme:
Evidence Based Practice
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593168/
https://ncbi.nlm.nih.gov/pubmed/26399574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-008689
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki